Aramis Biosciences, Inc.
PrivateLast Round
Series A
Dec 15, 2021
Total Funding Raised
$19.5M
Company Overview
Aramis Biosciences, Inc. operates in Healthcare & Life Sciences and is based in Medfield, Massachusetts. Its latest recorded funding round was a Series A round in December 2021.
Aramis Biosciences, Inc. is a clinical-stage immuno-ophthalmology biopharmaceutical company developing disease-modifying therapies for ocular surface diseases such as Dry Eye Disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B2C
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aramis Biosciences, Inc. Comparables
Compare Aramis Biosciences, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| iView Therapeutics | 81% | |
| Stuart Therapeutics, Inc. | 81% | |
| Azura Ophthalmics | 81% |
For institutional investors. Book with your work email.
Aramis Biosciences, Inc. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Aramis Biosciences, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Safar Partners | Series A |
| Santen Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors grew 152% MoM.
- Apr 19, 2026
Monthly visitors grew 259% MoM, reaching 1.1K.
For institutional investors. Book with your work email.
Aramis Biosciences, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Aramis Biosciences, Inc.'s valuation, stock price, and market status.
Is Aramis Biosciences, Inc. a public or private company?
Aramis Biosciences, Inc. is a private company.
What is the current stock price of Aramis Biosciences, Inc.?
Aramis Biosciences, Inc. is a private company, so its shares have no public market price. Caplight tracks Aramis Biosciences, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Aramis Biosciences, Inc. worth (valuation)?
Valuation information for Aramis Biosciences, Inc. is not publicly available.
Can I buy Aramis Biosciences, Inc. stock?
Aramis Biosciences, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Aramis Biosciences, Inc.'s last funding round?
Aramis Biosciences, Inc.'s most recent funding round was Series A on December 15, 2021.
Who are the main investors in Aramis Biosciences, Inc.?
Key investors in Aramis Biosciences, Inc. include Safar Partners.
Will Aramis Biosciences, Inc. IPO soon?
No public IPO plans have been announced for Aramis Biosciences, Inc..
How can I track Aramis Biosciences, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Aramis Biosciences, Inc.'s shares on secondary markets.